Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Non Operating Income: 2023-2024

Historic Non Operating Income for InMed Pharmaceuticals (INM) over the last 2 years, with Jun 2024 value amounting to $527,901.

  • InMed Pharmaceuticals' Non Operating Income fell 30.29% to $103,421 in Q2 2024 from the same period last year, while for Jun 2024 it was $528,803, marking a year-over-year change of. This contributed to the annual value of $527,901 for FY2024, which is 7.20% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Non Operating Income of $527,901 as of FY2024, which was up 7.20% from $492,440 recorded in FY2023.
  • InMed Pharmaceuticals' 5-year Non Operating Income high stood at $527,901 for FY2024, and its period low was $492,440 during FY2023.
  • In the last 2 years, InMed Pharmaceuticals' Non Operating Income had a median value of $510,170 in 2023 and averaged $510,170.
  • Data for InMed Pharmaceuticals' Non Operating Income shows a peak YoY rose of 7.20% (in 2024) over the last 5 years.
  • InMed Pharmaceuticals' Non Operating Income (Yearly) stood at $492,440 in 2023, then increased by 7.20% to $527,901 in 2024.